Literature DB >> 17165438

Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy.

Colleen M Feltmate1, Whitfield B Growdon, Adam J Wolfberg, Donald P Goldstein, David R Genest, Manuel E Chinchilla, Ellice S Lieberman, Ross S Berkowitz.   

Abstract

OBJECTIVE: To identify clinical characteristics associated with developing persistent gestational trophoblastic neoplasia (GTN) after partial hydatidiform molar pregnancy (PHM). STUDY
DESIGN: Utilizing the Donald P. Goldstein in patients who developed persistence between 1973 and 1989.
CONCLUSION: Older age at diagnosis and history of prior mole were significantly more common in women who developed persistence after partial molar pregnancy in referral of patients the earlier cohort but not in idefined clinical the recent cohort. In recent years no clinical factor was at increase their risk significantly associated with rsistence. database at the New England Trophoblastic Disease Center, 284 women with partial molar pregnancy diagnosed between 1973 and 2003 were characteristics identified. Clinical charac- for pe teristics, such as gravidity, parity, age, uterine size, gestational age at diagnosis, human chorionic gonadotropin levels at presentation and time to development of persistence (GTN) were analyzed. Data were also divided into 2 cohorts, an earlier one (1973-1989) and a later one (1990-2003), in order to look at potential changes over time.
RESULTS: GTN developed in 5.6% of partial molar pregnancies. Older maternal age was significantly associated with development of persistent GTN in the earlier cohort but not in the recent cohort. Previous molar pregnancy was also statistically significantly more common the development of +/-after PHM.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17165438

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  10 in total

1.  Abnormal villous morphology associated with triple trisomy of paternal origin.

Authors:  Alexis Norris-Kirby; Jill M Hagenkord; Malti P Kshirsagar; Brigitte M Ronnett; Kathleen M Murphy
Journal:  J Mol Diagn       Date:  2010-04-22       Impact factor: 5.568

2.  Molecular genotyping of hydatidiform moles: analytic validation of a multiplex short tandem repeat assay.

Authors:  Kathleen M Murphy; Thomas G McConnell; Michael J Hafez; Russell Vang; Brigitte M Ronnett
Journal:  J Mol Diagn       Date:  2009-10-08       Impact factor: 5.568

3.  Diagnosis of hydatidiform moles by polymorphic deletion probe fluorescence in situ hybridization.

Authors:  Sarah Chiang; Ladan Fazlollahi; Anhthu Nguyen; Rebecca A Betensky; Drucilla J Roberts; A John Iafrate
Journal:  J Mol Diagn       Date:  2011-04-29       Impact factor: 5.568

4.  STR DNA genotyping of hydatidiform moles in South China.

Authors:  Xing-Zheng Zheng; Pei Hui; Bin Chang; Zhi-Bin Gao; Yan Li; Bing-Quan Wu; Bo Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

5.  Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis.

Authors:  Russell Vang; Mamta Gupta; Lee-Shu-Fune Wu; Anna V Yemelyanova; Robert J Kurman; Kathleen M Murphy; Cheryl Descipio; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2012-03       Impact factor: 6.394

6.  Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis for both recently trained and experienced gynecologic pathologists.

Authors:  Mamta Gupta; Russell Vang; Anna V Yemelyanova; Robert J Kurman; Fanghong Rose Li; Emily C Maambo; Kathleen M Murphy; Cheryl DeScipio; Carol B Thompson; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2012-12       Impact factor: 6.394

7.  The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study.

Authors:  Eiko Yamamoto; Tien Dat Trinh; Yoko Sekiya; Koji Tamakoshi; Xuan Phuoc Nguyen; Kimihiro Nishino; Kaoru Niimi; Tomomi Kotani; Hiroaki Kajiyama; Kiyosumi Shibata; Quang Thanh Le; Fumitaka Kikkawa
Journal:  Nagoya J Med Sci       Date:  2020-05       Impact factor: 1.131

8.  Complete hydatidiform mole with a twin pregnancy at 26 weeks: a rare obstetric complication.

Authors:  Jain Deepti
Journal:  Autops Case Rep       Date:  2019-09-27

9.  Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping: updated analysis of a prospective series of 2217 cases.

Authors:  Deyin Xing; Emily Adams; Jialing Huang; Brigitte M Ronnett
Journal:  Mod Pathol       Date:  2020-10-06       Impact factor: 7.842

10.  Loss of p57 Expression in Conceptions Other Than Complete Hydatidiform Mole: A Case Series With Emphasis on the Etiology, Genetics, and Clinical Significance.

Authors:  Deyin Xing; Karin Miller; Katie Beierl; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2022-01-01       Impact factor: 6.298

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.